Literature DB >> 21531141

Design, synthesis and pharmacological evaluation of spirocyclic σ(1) receptor ligands with exocyclic amino moiety (increased distance 1).

Elisabeth Rack1, Roland Fröhlich, Dirk Schepmann, Bernhard Wünsch.   

Abstract

Various pharmacophore models for potent σ(1) ligands specify a basic amino group flanked by two different hydrophobic regions in defined distances to the basic amine (distance 1 and distance 2, respectively). According to these models distance 1 of the potent spirocyclic σ(1) ligand 1 is too short. In order to find a new class of more potent σ(1) ligands and to verify the distance hypothesis of the pharmacophore models spirocyclic compounds 2 with an exocyclic amino group were designed and synthesized. The secondary amines 8 and 9 with N-benzyl residues are >100-fold less potent than the spirocyclic piperidine 1. However, the tertiary methylamines trans-11 and cis-11 represent potent σ(1) ligands with K(i)-values of 43 and 24 nM, respectively. Whereas one large benzyl moiety is required for high σ(1) receptor binding, a second large N-substituent is not tolerated by the σ(1) receptor protein. As a rule, cis-configured diastereomers with a longer distance 1 (predominantly 7.16-7.23 Å) show higher σ(1) affinities than their trans-configured counterparts (distance 1 is predominantly 5.88-6.26 Å).
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21531141     DOI: 10.1016/j.bmc.2011.04.002

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Synthesis of σ Receptor Ligands with a Spirocyclic System Connected with a Tetrahydroisoquinoline Moiety via Different Linkers.

Authors:  Melanie Bergkemper; Dirk Schepmann; Bernhard Wünsch
Journal:  ChemMedChem       Date:  2021-02-02       Impact factor: 3.466

2.  Synthesis and σ receptor affinity of spiro[[2]benzopyran-1,1'-cyclohexanes] with an exocyclic amino moiety in the 3'-position.

Authors:  Elisabeth Kronenberg; Frauke Weber; Dirk Schepmann; Bernhard Wünsch
Journal:  RSC Med Chem       Date:  2020-12-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.